IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships

IQVIA and Veeva have announced long-term clinical and commercial partnerships, resolving all pending legal disputes. The partnerships aim to improve efficiency and effectiveness for customers by allowing them to use software, data, technology, and service offerings from both companies together. Key areas of collaboration include commercial and clinical solutions, with IQVIA and Veeva establishing master data and software third-party access agreements. The partnerships will enable customers to work with IQVIA and Veeva in areas such as master data management, analytics, and artificial intelligence.

Title: IQVIA and Veeva Announce Long-Term Clinical and Commercial Partnerships

IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) have announced long-term clinical and commercial partnerships, resolving all pending legal disputes. The partnerships aim to improve efficiency and effectiveness for customers by allowing them to use software, data, technology, and service offerings from both companies together. Key areas of collaboration include commercial and clinical solutions, with IQVIA and Veeva establishing master data and software third-party access agreements. The partnerships will enable customers to work with IQVIA and Veeva in areas such as master data management, analytics, and artificial intelligence.

Under the terms of the long-term agreement, customers can use software, data, technology, and service offerings from Veeva and IQVIA together in a simple and efficient way. The global partnerships make it easy for customers to work with IQVIA and Veeva in key areas including master data and software third-party access (TPA) agreements that allow IQVIA or Veeva data to be used with each other's software or services in customer instances, including the use of IQVIA data in Veeva Network for master data management (MDM), Veeva Nitro for analytics, and Veeva AI. In addition to the use of Veeva data in IQVIA's commercial products and services, IQVIA has also joined the Veeva Technology, AI, and Services Partner Programs to support customer integrations between Veeva software and IQVIA Analytics, IQVIA Information Management (including MDM), IQVIA Agentic AI, and IQVIA Commercial Orchestration offerings. With these partnerships and overall master agreements in place, customers also benefit from a fast, easy process to get TPAs for projects.

In the clinical realm, IQVIA has joined Veeva's CRO Clinical Data Partner program and can leverage the Veeva Clinical Suite to execute clinical trials using Veeva software products, including study builds with Veeva EDC. With this partnership, customers will benefit from IQVIA's clinical data management, clinical technology solutions, and EDC programming expertise with Veeva software to accelerate database builds, study locks, and data delivery.

Veeva founder and CEO Peter Gassner stated, "We are committed to supporting frictionless product and services integration with IQVIA for the benefit of our joint customers and the industry overall. I am excited about the potential for our clinical and commercial partnerships to create significant value for our shared customers." IQVIA chairman and CEO Ari Bousbib added, "IQVIA and Veeva's partnerships bring together best-in-class capabilities in information, AI, technology, and services for our shared clients. This will enable IQVIA customers on Veeva platforms to accelerate clinical development, bring treatments to market more efficiently, and improve access to innovations for patients."

The partnerships underscore the importance of collaboration in the biopharmaceutical industry, where integrating advanced technologies and data management solutions can significantly enhance clinical trials and commercial operations. IQVIA and Veeva's combined expertise in clinical research, data management, and analytics positions them as leaders in driving innovation and efficiency in the life sciences sector.

References
[1] https://www.prnewswire.com/news-releases/iqvia-and-veeva-announce-long-term-clinical-and-commercial-partnerships-and-resolution-of-all-disputes-302531726.html
[2] https://www.linkedin.com/jobs/view/sales-data-management-specialist-at-motion-recruitment-4286946338
[3] https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/can-iqvia-iqv-leverage-new-partnerships-to-reinforce-its-glo